<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">30043913</article-id><article-id pub-id-type="pmc">6089122</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2017-0214</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Effect of Plasma Level of Vitamin D on Postoperative Atrial
Fibrillation in Patients Undergoing Isolated Coronary Artery Bypass
Grafting</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>&#x000d6;zsin</surname><given-names>Kadir Kaan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Sanr&#x00131;</surname><given-names>Umut Serhat</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Tokta&#x0015f;</surname><given-names>Faruk</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Kahraman</surname><given-names>Nail</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Yavuz</surname><given-names>&#x0015e;enol</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><aff id="aff1">
<label>1</label>Department of Cardiovascular Surgery, Bursa Yuksek Ihtisas
Training and Research Hospital, University of Health Sciences,
Y&#x00131;ld&#x00131;r&#x00131;m/Bursa, Turkey.</aff></contrib-group><author-notes><corresp id="c1">Correspondence Address: Kadir Kaan &#x000d6;zsin, Department of
Cardiovascular Surgery, University of Health Sciences, Bursa Yuksek Ihtisas
Training and Research Hospital, Prof. Tezok Street 152 -Evler -
Y&#x00131;ld&#x00131;r&#x00131;m/Bursa, Turkey - Zip Code: 16320. E-mail:
<email>kkozsin@gmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>May-Jun</season><year>2018</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>May-Jun</season><year>2018</year></pub-date><volume>33</volume><issue>3</issue><fpage>217</fpage><lpage>223</lpage><history><date date-type="received"><day>10</day><month>11</month><year>2017</year></date><date date-type="accepted"><day>20</day><month>12</month><year>2017</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Objective</title><p>Postoperative atrial fibrillation (PoAF) is a common complication after
coronary artery bypass grafting (CABG). The aim of the present study was to
evaluate the association between development of PoAF and vitamin D levels in
patients undergoing isolated CABG.</p></sec><sec><title>Methods</title><p>This prospective randomized clinical trial was conducted on the patients with
isolated CABG. The study was terminated when 50 patients in both PoAF(+)
group and PoAF(-) group were reached. Development of AF until discharge
period was assessed. Vitamin D level was measured immediately after AF; it
was measured on the discharge day for the patients without PoAF. Predictive
values of the independent variables were measured for the development of
PoAF.</p></sec><sec><title>Results</title><p>The groups were separated as PoAF(-) group (66% male, mean age
58.18&#x000b1;10.98 years) and PoAF(+) group (74% male, mean age
61.94&#x000b1;10.88 years). 25(OH) vitamin D level (OR=0.855, 95% CI:
0.780-0.938, <italic>P</italic>=0.001) and &#x0003e; 65 years (OR=3.525, 95% CI:
1.310-9.483, <italic>P</italic>=0.013) were identified as an independent
predictor of postoperative AF after CABG surgery in multivariate analysis.
The cut-off level for 25(OH) vitamin D level in receiver-operating
characteristic curve analysis was determined as 7.65 with sensitivity of 60%
and specificity of 64% for predicting PoAF (area under the curve: 0.679,
<italic>P</italic>=0.002).</p></sec><sec><title>Conclusion</title><p>Vitamin D level is considered an independent predictor for development of
PoAF. Lower vitamin D levels may be one of the reasons for PoAF.</p></sec></abstract><kwd-group><kwd>Vitamin D</kwd><kwd>Postoperative Period</kwd><kwd>Atrial Fibrillation</kwd><kwd>Coronary Artery Bypass</kwd></kwd-group></article-meta></front><body><table-wrap id="t4" orientation="portrait" position="float"><table frame="hsides" rules="groups"><colgroup span="1"><col width="20%" span="1"/><col width="80%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="background-color:#e6e7e8" rowspan="1">Abbreviations,
acronyms &#x00026; symbols</th></tr></thead><tbody><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">25(OH) vitamin D</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= 25-hydroxy vitamin
D</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ACE</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Angiotensin-converting
enzyme</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">AF</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Atrial fibrillation</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ARB</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Angiotensin receptor
blocker</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CABG</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Coronary artery bypass
grafting</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Confidence interval</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">COPD</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Chronic obstructive
pulmonary disease</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CPB</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Cardiopulmonary
bypass</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ECG</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Electrocardiography</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ICU</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Intensive care unit</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">OR</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Odds ratio</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PoAF</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Postoperative atrial
fibrillation</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">RAAS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">=
Renin-angiotensin-aldosterone system</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ROC</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Receiver-operating
characteristic curve</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Postoperative atrial fibrillation (PoAF) is a common complication after coronary
artery bypass grafting (CABG), affecting about 20% to 35% of all patients in the
early postoperative period<sup>[</sup><sup><xref rid="r1" ref-type="bibr">1</xref></sup><sup>]</sup>. PoAF is commonly associated with hemodynamic
instability, thromboembolic events, increase in early and late mortality rates,
heart failure progression and increased duration of
hospitalization<sup>[</sup><sup><xref rid="r1" ref-type="bibr">1</xref></sup><sup>]</sup>.</p><p>Vitamin D exists in two forms: D2 (ergocalciferol) and D3 (cholecalciferol). Vitamin
D is converted into calcidiol and calcitriol, respectively in the liver and kidney;
and acts on specific target tissues via vitamin D receptors<sup>[</sup><sup><xref rid="r2" ref-type="bibr">2</xref></sup><sup>]</sup>. Vitamin D receptors
were found in other extra-osseous tissues, as well as all major cardiovascular cell
types, including cardiomyocytes, vascular smooth muscle cells, endothelial cells,
the brain, pancreatic beta-cells, skeletal muscles, breast, prostate, colon,
macrophages, and skin, exerting several pleiotropic effects, and their expression
decreases with age<sup>[</sup><sup><xref rid="r3" ref-type="bibr">3</xref></sup><sup>]</sup>.</p><p>Deficiency of vitamin D may cause a number of diseases. Some of these diseases
include type 2 diabetes mellitus, metabolic syndrome, obesity, hypertension, and
some cardiovascular disease<sup>[</sup><sup><xref rid="r4" ref-type="bibr">4</xref></sup><sup>]</sup>. Several pathophysiological mechanisms were
suggested for the association between vitamin D deficiency and atrial fibrillation
(AF). One of the most important mechanisms is the activation of the
renin-angiotensin-aldosterone system (RAAS), as it is responsible for both
structural and electrical remodeling of the atrium. Vitamin D negatively affects the
RAAS, and it has antioxidant effects that reduce oxygen free radicals in the atria
which are associated with inflammation and the production of proarrhythmic
materials<sup>[</sup><sup><xref rid="r5" ref-type="bibr">5</xref></sup><sup>]</sup>.</p><p>Presence of vitamin D receptor in extra-osseous tissues; and the link between vitamin
D and the RAAS may be shown relationship between vitamin D and AF risk factors. The
aim of this study was to determined the relationship between vitamin D levels and
PoAF in patients undergoing isolated CABG.</p></sec><sec sec-type="methods"><title>METHODS</title><sec><title>The Patients</title><p>This prospective randomized clinical trial was conducted on the patients with
isolated CABG diagnosed at of Cardiovascular Surgery Department within Bursa
Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey, between November
2016 and May 2017. The study was approved by the local institutional Ethical
Committee of the University of Health Sciences. All procedures were performed in
accordance with the Declaration of Helsinki.</p><p>Inclusion criteria was isolated CABG. The exclusion criterias were having
preoperative AF or flutter, previous treatment with amiodarone, presence of
valvular heart disease, chronic obstructive pulmonary disease (COPD), prolonged
intensive care unit (ICU) stay, patients who underwent more than one cardiac
surgery, bleeding revision, chronic renal failure. Patients who underwent
isolated CABG were followed until the day of discharge from the hospital.
Patients who developed AF during the this period were included in the POAF(+)
group, and patients without AF were enrolled in the PoAF(-) group. The study was
terminated when 50 patients were reached in both groups.</p><p>The data of PoAF(+) group (74% male, mean age 61.94&#x000b1;10.88 years) and
PoAF(-) group (66% male, mean age 58.18&#x000b1;10.98 years) are shown in <xref rid="t1" ref-type="table">Table 1</xref>.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Demographic features of the patients.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="40%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">PoAF(+) group<break/>(n=50)</th><th align="center" rowspan="1" colspan="1">PoAF(-) group<break/>(n=50)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic> value<xref ref-type="table-fn" rid="TFN1">*</xref></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="center" rowspan="1" colspan="1">61.94&#x000b1;10.88</td><td align="center" rowspan="1" colspan="1">58.18&#x000b1;10.98</td><td align="center" rowspan="1" colspan="1">0.089</td></tr><tr><td align="left" rowspan="1" colspan="1">Age &#x02265; 65 years, n (%)</td><td align="center" rowspan="1" colspan="1">22 (44)</td><td align="center" rowspan="1" colspan="1">12 (24)</td><td align="center" rowspan="1" colspan="1">0.035</td></tr><tr><td align="left" rowspan="1" colspan="1">Male gender, n (%)</td><td align="center" rowspan="1" colspan="1">37 (74)</td><td align="center" rowspan="1" colspan="1">33 (66)</td><td align="center" rowspan="1" colspan="1">0.383</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypertension, n (%)</td><td align="center" rowspan="1" colspan="1">26 (52)</td><td align="center" rowspan="1" colspan="1">22 (44)</td><td align="center" rowspan="1" colspan="1">0.423</td></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes mellitus, n (%)</td><td align="center" rowspan="1" colspan="1">23 (46)</td><td align="center" rowspan="1" colspan="1">21 (42)</td><td align="center" rowspan="1" colspan="1">0.687</td></tr><tr><td align="left" rowspan="1" colspan="1">Beta-blocker therapy, n (%)</td><td align="center" rowspan="1" colspan="1">38 (76)</td><td align="center" rowspan="1" colspan="1">32 (64)</td><td align="center" rowspan="1" colspan="1">0.190</td></tr><tr><td align="left" rowspan="1" colspan="1">Statin therapy, n (%)</td><td align="center" rowspan="1" colspan="1">31 (62)</td><td align="center" rowspan="1" colspan="1">29 (58)</td><td align="center" rowspan="1" colspan="1">0.683</td></tr><tr><td align="left" rowspan="1" colspan="1">ACE-I/ARB therapy, n (%)</td><td align="center" rowspan="1" colspan="1">22 (44)</td><td align="center" rowspan="1" colspan="1">20 (40)</td><td align="center" rowspan="1" colspan="1">0.685</td></tr><tr><td align="left" rowspan="1" colspan="1">BSA</td><td align="center" rowspan="1" colspan="1">1.85&#x000b1;0.16</td><td align="center" rowspan="1" colspan="1">1.87&#x000b1;0.16</td><td align="center" rowspan="1" colspan="1">0.719</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI</td><td align="center" rowspan="1" colspan="1">27.69&#x000b1;4.48</td><td align="center" rowspan="1" colspan="1">27.56&#x000b1;4.06</td><td align="center" rowspan="1" colspan="1">0.881</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><label>*</label><p>Student's t test; Pearson Chi-square</p></fn><fn id="TFN2"><p>ACE-I=angiotensin-converting enzyme inhibitor;
ARB=angiotensin-receptor blocker; BMI=body mass index; BSA=body
surface area; PoAF=postoperative atrial fibrillation</p></fn></table-wrap-foot></table-wrap><p>All data were recorded as age, gender, history of hypertension, diabetes
mellitus, preoperative drug use [beta-blockers, statins, angiotensin-converting
enzyme (ACE) or angiotensin receptor blocker (ARB) inhibitors], ejection
fraction, left atrial diameter, body mass index, body surface area, aortic cross
clamp time, cardiopulmonary bypass time. Laboratory parameters were also studied
from venous blood sample before the surgery except for 25-OH vitamin D levels.
In the PoAF(+) group, the level of vitamin D was measured immediately after
development AF. In the group of PoAF (-), the level of vitamin D was measured on
the day patients were discharged from the hospital.</p><p>The inactive vitamin D precursors are first exposed to 25-hydroxylation in the
liver to form 25-hydroxy vitamin D [(25(OH) vitamin D]. This is the actual
circulating form of vitamin D and therefore is usually considered as a
circulating biomarker for vitamin D status<sup>[</sup><sup><xref rid="r6" ref-type="bibr">6</xref></sup><sup>]</sup>.</p><p>The 25-OH vitamin D levels were measured through Architect 25-OH vitamin D-
Reagent Kit (Abbott, Diagnostic Division Lisnamuck, Longford, Ireland).
Reference ranges of the 25-OH vitamin D Kit used were 6.2 to 45.5 ng/mL for
winter season and 7 to 53.2 ng/mL for summer season.</p></sec><sec><title>Diagnosis of PoAF</title><p>The patients were monitored in ICU with continuous heart rhythm and invasive
blood pressure monitoring. In addition, a 12-lead electrocardiography (ECG)
record was also obtained daily in the ICU. Patients were monitored continuously
by five-lead telemetry in the regular ward. When the patients complained about
palpitation, dyspnea and angina, 12-lead ECG was taken. AF was confirmed by
12-lead ECG. Postoperative AF was described as irregular, fast oscillations or
fibrillatory waves instead of regular <italic>P</italic> waves at ECG. An AF
episode longer than 5 minutes was accepted as PoAF. Standard medical
cardioversion treatment was conducted with amiodarone (5 mg/kg) for 30 minutes,
followed by 900 mg/day.</p></sec><sec><title>Statistical Analysis</title><p>Statistical analysis data were analyzed with the Statistical Package for the
Social Sciences (IBM SPSS Statistic Inc. version 21.0, Chicago, IL, USA).
Continuous and ordinal variables were expressed as mean &#x000b1; standard
deviation and nominal variables were expressed as frequency and percentage.
Kolmogorov-Smirnov test and Shapiro-Wilk tests of normality were used to
identify distribution of variables. Student's t test was used to compare two
groups for continuous variables with normal distribution. Chi Square test was
used to compare two groups for nominal variables. Mann-Whitney U test was used
to compare two groups for continuous variables without normal distribution. For
all tests, a <italic>P</italic> value of &#x0003c;0.05 was considered statistically
significant. The relationship between the preoperative independent variables and
the development of postoperative AF was evaluated by a logistic regression
analysis. Receiver-operating characteristic (ROC) curve was applied for the
prediction of PoAF development in patients undergoing isolated CABG and the area
under the curve was calculated for vitamin D levels.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>In the present study, 50 patients were enrolled into each group. The demographic and
clinical characteristics of the participants are summarized in <xref rid="t1" ref-type="table">Table 1</xref>. Being over 65 years of age was
evaluated as a different parameter. Patients with PoAF were similar to patients
without PoAF in regards to demographic properties, in generally. But, in terms of in
patients with age &#x0003e; 65 years was statistically significant difference between two
groups (<italic>P</italic>=0.035) (<xref rid="t1" ref-type="table">Table
l</xref>).</p><p>The comparison of laboratory and operative parameters are shown in <xref rid="t2" ref-type="table">Table 2</xref>. Significant difference only was
observed between two groups in terms of 25(OH) vitamin D levels. Twenty-five(OH)
vitamin D level were significantly lower in the PoAF group
(<italic>P</italic>=0.002) (<xref rid="t2" ref-type="table">Table 2</xref>).
However, all other parameters were not significantly different between the groups
(<xref rid="t2" ref-type="table">Table 2</xref>).</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Laboratory and operative variables.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="40%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">PoAF group<break/>(n=50)</th><th align="center" rowspan="1" colspan="1">PoAF(-) group<break/>(n=50)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic> value<xref ref-type="table-fn" rid="TFN3">*</xref></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Hematocrit (%)</td><td align="center" rowspan="1" colspan="1">39.37&#x000b1;5.53</td><td align="center" rowspan="1" colspan="1">41.16&#x000b1;4.69</td><td align="center" rowspan="1" colspan="1">0.244</td></tr><tr><td align="left" rowspan="1" colspan="1">White blood cell (10<sup>3</sup>/&#x000b5;L)</td><td align="center" rowspan="1" colspan="1">9.18&#x000b1;2.14</td><td align="center" rowspan="1" colspan="1">9.55&#x000b1;2.87</td><td align="center" rowspan="1" colspan="1">0.733</td></tr><tr><td align="left" rowspan="1" colspan="1">Platelet (10<sup>3</sup>/&#x000b5;L)</td><td align="center" rowspan="1" colspan="1">268.98&#x000b1;91.2</td><td align="center" rowspan="1" colspan="1">237.56&#x000b1;54.69</td><td align="center" rowspan="1" colspan="1">0.126</td></tr><tr><td align="left" rowspan="1" colspan="1">Red cell distribution width (%)</td><td align="center" rowspan="1" colspan="1">13.76&#x000b1;1.13</td><td align="center" rowspan="1" colspan="1">13.98&#x000b1;1.25</td><td align="center" rowspan="1" colspan="1">0.456</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean platelet volume (fL)</td><td align="center" rowspan="1" colspan="1">8.91&#x000b1;0.98</td><td align="center" rowspan="1" colspan="1">8.66&#x000b1;0.86</td><td align="center" rowspan="1" colspan="1">0.208</td></tr><tr><td align="left" rowspan="1" colspan="1">BUN (mg/dL)</td><td align="center" rowspan="1" colspan="1">18.04&#x000b1;7.71</td><td align="center" rowspan="1" colspan="1">17.78&#x000b1;7.39</td><td align="center" rowspan="1" colspan="1">0.803</td></tr><tr><td align="left" rowspan="1" colspan="1">Creatinine (mg/dL)</td><td align="center" rowspan="1" colspan="1">0.88&#x000b1;0.21</td><td align="center" rowspan="1" colspan="1">0.89&#x000b1;0.32</td><td align="center" rowspan="1" colspan="1">0.545</td></tr><tr><td align="left" rowspan="1" colspan="1">Na (mEq/L)</td><td align="center" rowspan="1" colspan="1">138.3&#x000b1;3.07</td><td align="center" rowspan="1" colspan="1">138.64&#x000b1;2.46</td><td align="center" rowspan="1" colspan="1">0.534</td></tr><tr><td align="left" rowspan="1" colspan="1">K (mEq/L)</td><td align="center" rowspan="1" colspan="1">4.17&#x000b1;0.42</td><td align="center" rowspan="1" colspan="1">4.14&#x000b1;0.6</td><td align="center" rowspan="1" colspan="1">0.673</td></tr><tr><td align="left" rowspan="1" colspan="1">Ca (mg/dL)</td><td align="center" rowspan="1" colspan="1">9.09&#x000b1;0.42</td><td align="center" rowspan="1" colspan="1">9.17&#x000b1;0.51</td><td align="center" rowspan="1" colspan="1">0.269</td></tr><tr><td align="left" rowspan="1" colspan="1">Mg (mg/dL)</td><td align="center" rowspan="1" colspan="1">1.91&#x000b1;0.15</td><td align="center" rowspan="1" colspan="1">1.9&#x000b1;0.22</td><td align="center" rowspan="1" colspan="1">0.816</td></tr><tr><td align="left" rowspan="1" colspan="1">Free T3 (pg/mL)</td><td align="center" rowspan="1" colspan="1">2.94&#x000b1;0.45</td><td align="center" rowspan="1" colspan="1">2.95&#x000b1;0.44</td><td align="center" rowspan="1" colspan="1">0.959</td></tr><tr><td align="left" rowspan="1" colspan="1">Free T4 (ng/dL)</td><td align="center" rowspan="1" colspan="1">1.11&#x000b1;0.19</td><td align="center" rowspan="1" colspan="1">1.17&#x000b1;0.21</td><td align="center" rowspan="1" colspan="1">0.166</td></tr><tr><td align="left" rowspan="1" colspan="1">TSH (IU/mL)</td><td align="center" rowspan="1" colspan="1">1.96&#x000b1;1.19</td><td align="center" rowspan="1" colspan="1">2.92&#x000b1;4.72</td><td align="center" rowspan="1" colspan="1">0.608</td></tr><tr><td align="left" rowspan="1" colspan="1">C reactive protein (mg/dL)</td><td align="center" rowspan="1" colspan="1">14.73&#x000b1;23.40</td><td align="center" rowspan="1" colspan="1">12.7&#x000b1;19.09</td><td align="center" rowspan="1" colspan="1">0.871</td></tr><tr><td align="left" rowspan="1" colspan="1">Total cholesterol (mg/dl)</td><td align="center" rowspan="1" colspan="1">202.5&#x000b1;33.41</td><td align="center" rowspan="1" colspan="1">197.92&#x000b1;39.96</td><td align="center" rowspan="1" colspan="1">0.536</td></tr><tr><td align="left" rowspan="1" colspan="1">LDL-C (mg/dL)</td><td align="center" rowspan="1" colspan="1">128.11&#x000b1;29.44</td><td align="center" rowspan="1" colspan="1">119.37&#x000b1;33.57</td><td align="center" rowspan="1" colspan="1">0.596</td></tr><tr><td align="left" rowspan="1" colspan="1">HDL-C (mg/dL)</td><td align="center" rowspan="1" colspan="1">43.38&#x000b1;8.36</td><td align="center" rowspan="1" colspan="1">41.55&#x000b1;8.43</td><td align="center" rowspan="1" colspan="1">0.316</td></tr><tr><td align="left" rowspan="1" colspan="1">TG (mg/dL)</td><td align="center" rowspan="1" colspan="1">153.38&#x000b1;65.66</td><td align="center" rowspan="1" colspan="1">184.44&#x000b1;111.41</td><td align="center" rowspan="1" colspan="1">0.237</td></tr><tr><td align="left" rowspan="1" colspan="1">25(OH) vitamin D (ng/mL)</td><td align="center" rowspan="1" colspan="1">7.49&#x000b1;3.81</td><td align="center" rowspan="1" colspan="1">12.13&#x000b1;7.98</td><td align="center" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" rowspan="1" colspan="1">Ejection fraction (%)</td><td align="center" rowspan="1" colspan="1">51.14&#x000b1;9.09</td><td align="center" rowspan="1" colspan="1">50.20&#x000b1;9.42</td><td align="center" rowspan="1" colspan="1">0.648</td></tr><tr><td align="left" rowspan="1" colspan="1">Left atrium diameter (mm)</td><td align="center" rowspan="1" colspan="1">38.40&#x000b1;4.22</td><td align="center" rowspan="1" colspan="1">38.08&#x000b1;4.15</td><td align="center" rowspan="1" colspan="1">0.928</td></tr><tr><td align="left" rowspan="1" colspan="1">ACC time (min)</td><td align="center" rowspan="1" colspan="1">58.32&#x000b1;14.99</td><td align="center" rowspan="1" colspan="1">57.04&#x000b1;14.38</td><td align="center" rowspan="1" colspan="1">0.473</td></tr><tr><td align="left" rowspan="1" colspan="1">CPB time (min)</td><td align="center" rowspan="1" colspan="1">88.04&#x000b1;20.99</td><td align="center" rowspan="1" colspan="1">86.72&#x000b1;1947</td><td align="center" rowspan="1" colspan="1">0.745</td></tr></tbody></table><table-wrap-foot><fn id="TFN3"><label>*</label><p>Student's-t test; Mann-Whitney U test</p></fn><fn id="TFN4"><p>25(OH) vitamin D=25-hydroxy vitamin D; ACC=aortic cross clamp; BUN=Blood
urea nitrogen; CPB=cardiopulmonary bypass; HDL-C=high density
lipoprotein cholesterol; LDL-C=low density lipoprotein cholesterol;
PoAF=postoperative atrial fibrillation; T3=triiodothyronine;
T4=thyroxine; TG=triglyceride; TSH=thyroid-stimulating hormone</p></fn></table-wrap-foot></table-wrap><p>Risk factors related to the development of PoAF were included univariate logistic
regression analysis. In univariate logistic regression analysis, the PoAF was
significantly correlated with 25(OH) vitamin D level (OR [odds ratio]=0.867, 95% CI
[Confidence interval]: 0.793-0.949, <italic>P</italic>=0.002) and age &#x0003e; 65 years
(OR=0.402, 95% CI: 0.171-.946, <italic>P</italic>=0.037), but was not correlated
with age (OR=1.032, 95% CI: 0.995-1.071, <italic>P</italic>=0.091), hypertension
(OR=1.379, 95% CI: 0.628-3.029, <italic>P</italic>=0.424), diabetes mellitus
(OR=1.176, 95% CI: 0.534-2.593, <italic>P</italic>=0.687), ejection fraction
(OR=1.011, 95% CI: 0.969-1.055, <italic>P</italic>=0.609), left atrium diameter
(OR=1.019, 95% CI: 0.927-1.120, <italic>P</italic>=0.700) and cardiopulmonary bypass
(CPB) time (OR=1.003, 95% CI: 0.984-1.023, <italic>P</italic>=0.742) (<xref rid="t3" ref-type="table">Table 3</xref>). Similar to the results in the
univariate analysis, 25(OH) vitamin D level (OR=0.855, 95% CI: 0.780-0.938,
<italic>P</italic>=0.001) and age &#x0003e; 65 years (OR=3.525, 95% CI: 1.310-9.483,
<italic>P</italic>=0.013) were identified as an independent predictor of
postoperative AF after CABG surgery in multivariate analysis (<xref rid="t3" ref-type="table">Table 3</xref>). Additionally, it was determined a cut-off level of
7.65 for 25(OH) vitamin D level for predicting PoAF with a sensitivity of 60% and a
specificity of 64%, in ROC curve analysis (area under the curve: 0.679, 95% CI:
0.576-0.783, <italic>P</italic>=0.002) (<xref ref-type="fig" rid="f1">Figure
1</xref>).</p><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Binary logistic regression analysis to identify predictors of PoAF.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="center" colspan="3" rowspan="1">Univariate Analysis</th><th align="center" colspan="3" rowspan="1">Multivariate analysis</th></tr><tr><th align="left" rowspan="1" colspan="1">Variables</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic>
</th><th align="center" rowspan="1" colspan="1">Exp(B)<break/>Odds ratio</th><th align="center" rowspan="1" colspan="1">95% C.I.<break/>Lower&#x000a0; Upper</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic>
</th><th align="center" rowspan="1" colspan="1">Exp(B)<break/>Odds ratio</th><th align="center" rowspan="1" colspan="1">95% C.I.<break/>Lower Upper</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age</td><td align="center" rowspan="1" colspan="1">0.091</td><td align="center" rowspan="1" colspan="1">1.032</td><td align="center" rowspan="1" colspan="1">0.995-1.071</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Age &#x02265; 65 years</td><td align="center" rowspan="1" colspan="1">0.037</td><td align="center" rowspan="1" colspan="1">0.402</td><td align="center" rowspan="1" colspan="1">0.171 - .946</td><td align="center" rowspan="1" colspan="1">0.013</td><td align="center" rowspan="1" colspan="1">3.525</td><td align="center" rowspan="1" colspan="1">1.310-9.483</td></tr><tr><td align="left" rowspan="1" colspan="1">HT</td><td align="center" rowspan="1" colspan="1">0.424</td><td align="center" rowspan="1" colspan="1">1.379</td><td align="center" rowspan="1" colspan="1">0.628-3.029</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">DM</td><td align="center" rowspan="1" colspan="1">0.687</td><td align="center" rowspan="1" colspan="1">1.176</td><td align="center" rowspan="1" colspan="1">0.534-2.593</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">EF</td><td align="center" rowspan="1" colspan="1">0.609</td><td align="center" rowspan="1" colspan="1">1.011</td><td align="center" rowspan="1" colspan="1">0.969-1.055</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">LAD</td><td align="center" rowspan="1" colspan="1">0.700</td><td align="center" rowspan="1" colspan="1">1.019</td><td align="center" rowspan="1" colspan="1">0.927-1.120</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">25(OH) Vitamin D</td><td align="center" rowspan="1" colspan="1">0.002</td><td align="center" rowspan="1" colspan="1">0.867</td><td align="center" rowspan="1" colspan="1">0.793 - .949</td><td align="center" rowspan="1" colspan="1">0.001</td><td align="center" rowspan="1" colspan="1">0.855</td><td align="center" rowspan="1" colspan="1">0.780-0.938</td></tr><tr><td align="left" rowspan="1" colspan="1">CPB time</td><td align="center" rowspan="1" colspan="1">0.742</td><td align="center" rowspan="1" colspan="1">1.003</td><td align="center" rowspan="1" colspan="1">0.984 -1.023</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr></tbody></table><table-wrap-foot><fn id="TFN5"><p>25(OH) vitamin D = 25-hydroxy vitamin D; CPB=cardiopulmonary bypass;
DM=diabetes mellitus; EF=ejection fraction; HT=hypertension; LAD=left
atrium diameter; PoAF=postoperative atrial fibrillation</p></fn></table-wrap-foot></table-wrap><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Receiver operation characteristic (ROC) curve and the area under the
curve (AUC) for vitamin D levels for predicting PoAF.</p></caption><graphic xlink:href="rbccv-33-03-0217-g01"/></fig>
</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>In our study, the effect of the vitamin D levels was assessed on development of PoAF
in patients who had isolated CABG. The association between lower vitamin D levels
and PoAF development was determined. Plasma 25 (OH) vitamin D levels was found
significantly lower in patients who developed PoAF than the patients with sinus
rhythm. In univariate and multivariate logistic regression analysis, lower plasma 25
(OH) vitamin D levels and age &#x0003e; 65 years were found to be an independent variable
predicting the development of PoAF. Also it was determined for cut-off level of 7.65
of vitamin D level for predicting PoAF with a sensitivity of 60% and a specificity
of 64% in ROC analysis.</p><p>The incidence of PoAF following CABG surgery is seen in 25%-40% of cases. However,
its frequency reaches to 62% following combined CABG and valve
surgery<sup>[</sup><sup><xref rid="r7" ref-type="bibr">7</xref></sup><sup>]</sup>. The risk of PoAF in valvular and combined surgery,
including coronary and valvular, was reported to be higher than that in coronary
surgery alone. Mariscalco et al.<sup>[</sup><sup><xref rid="r8" ref-type="bibr">8</xref></sup><sup>]</sup> identified the PoAF rates as 22.9%, 39.8%, and
45.2% for the isolated CABG, valve surgery, and combined surgery, respectively.
Therefore, patients with valvular heart disease were excluded to not affect on the
outcome of the study.</p><p>Postoperative hypoxemia was shown to be the most common cause of cardiac arrhythmias.
COPD is an independent risk factor for arrhythmias, especially for AF and
cardiovascular morbidity and mortality. In a large-scale, retrospective,
case-control study, patients with COPD had a 4.41 times higher risk of AF and COPD
is present in 10-15% of patients with AF<sup>[</sup><sup><xref rid="r9" ref-type="bibr">9</xref></sup><sup>]</sup>. Mathew et al.<sup>[</sup><sup><xref rid="r10" ref-type="bibr">10</xref></sup><sup>]</sup> have showed that COPD
increased the incidence of both persistent and paroxysmal AF and the incidence of
PoAF increased to 43% in the presence of COPD. For this reason, patients with COPD
were not included in order to make our results more accurate.</p><p>In majority of the studies, hypertension, diabetes mellitus, left atrium diameter and
low ejection fraction were shown to play a role in the development of
PoAF<sup>[</sup><sup><xref rid="r11" ref-type="bibr">11</xref></sup><sup>]</sup>. In our study, in terms of these parameters there were
not significantly different between the groups. However, these factors which are
effective in AF development are included in the logistic regression analysis. Any of
these variables were not significantly associated with development of PoAF. These
results may contribute to the effectiveness of the vitamin D level which measured
for predicting PoAF in this study.</p><p>Age-related changes, including atrial fibrosis and accumulation of amyloid, can cause
intraatrial reentry which leads to the development of AF<sup>[</sup><sup><xref rid="r12" ref-type="bibr">12</xref></sup><sup>]</sup>. Age has been
repeatedly shown to be the major risk factor for AF after cardiac
surgery<sup>[</sup><sup><xref rid="r13" ref-type="bibr">13</xref></sup><sup>]</sup>. In our study, significant difference was not
observed between two groups in terms of age. But, in terms of in patients with age
&#x0003e; 65 years was statistically significant difference between two groups. In our
study, in binary logistic regression analysis, age &#x0003e; 65 years was found to be an
independent variable predicting the development of PoAF. Cerit et
al.<sup>[</sup><sup><xref rid="r14" ref-type="bibr">14</xref></sup><sup>]</sup> found that age was significantly associated with
development of PoAF following CABG in univariate logistic regression analysis. In
another study, Ge&#x000e7;men et al.<sup>[</sup><sup><xref rid="r15" ref-type="bibr">15</xref></sup><sup>]</sup> showed that age was as an independent variable
predicting the development of PoAF in both univariate and multivariate logistic
regression analyses. It was found in two different studies that search the
relationship between vitamin D and AF in patients undergoing CABG that age was not
significantly associated with development of PoAF following
CABG<sup>[</sup><sup><xref rid="r16" ref-type="bibr">16</xref></sup><sup>,</sup><sup><xref rid="r17" ref-type="bibr">17</xref></sup><sup>]</sup>. Our results were generally consistent with the
literature. When age is considered as a risk factor, it is known by researchers that
elder patients have a risk for development AF.</p><p>The relationship between low 25(OH) vitamin D levels and AF has not been clarified
yet. Several studies demonstrated a close association between vitamin D deficiency
and AF. Demir et al.<sup>[</sup><sup><xref rid="r18" ref-type="bibr">18</xref></sup><sup>]</sup> found that the relationship between vitamin D
deficiency and non-valvular AF. Previous a study has shown that there is a
relationship between low vitamin D levels and increased C-reactive protein
levels<sup>[</sup><sup><xref rid="r19" ref-type="bibr">19</xref></sup><sup>]</sup>. The vitamin D has antioxidant properties that
protect against oxidative stress in the atrium<sup>[</sup><sup><xref rid="r20" ref-type="bibr">20</xref></sup><sup>]</sup>. Zhang et al.<sup>[</sup><sup><xref rid="r21" ref-type="bibr">21</xref></sup><sup>]</sup> in a meta-analysis
suggested that there is a positive association between vitamin D deficiency and the
risk of AF.</p><p>On the other hand, The Framingham Heart study, in which approximately 3000 patients
were included and follow-up for approximately 10 years. Rienstra et
al.<sup>[</sup><sup><xref rid="r22" ref-type="bibr">22</xref></sup><sup>]</sup> found that vitamin D status is not an important
contributor to AF in the general population. In a study in which they investigated
postoperative AF, Skuladottir et al.<sup>[</sup><sup><xref rid="r23" ref-type="bibr">23</xref></sup><sup>]</sup> found higher preoperative plasma 25(OH) vitamin
D2 levels to be associated with an increased risk of POAF. In contrast, they did not
observe an association between plasma levels of 25(OH) vitamin D3 or total 25(OH)
vitamin D and the incidence of POAF. In another prospective cohort study based on
the Rotterdam study, vitamin D level is not associated with AF<sup>[</sup><sup><xref rid="r5" ref-type="bibr">5</xref></sup><sup>]</sup>.</p><p>There are limited number of studies indicating the relationship between the vitamin D
levels and PoAF in patients undergoing isolated CABG. In one of these studies, Gode
et al.<sup>[</sup><sup><xref rid="r16" ref-type="bibr">16</xref></sup><sup>]</sup>
reported that 25(OH) vitamin D level were significantly lower in the PoAF group
(<italic>P</italic>=0.007). In two similar studies, investigators found that
there was no relationship between lower 25(OH) vitamin D levels and
AF<sup>[</sup><sup><xref rid="r14" ref-type="bibr">14</xref></sup><sup>,</sup><sup><xref rid="r17" ref-type="bibr">17</xref></sup><sup>]</sup>. In our study, 25(OH) vitamin D level were
significantly lower in the PoAF(+) group (<italic>P</italic>=0.002). Also, in our
study, both in univariate logistic regression analysis and in multivariate logistic
regression analysis, lower vitamin D levels were found to be as independent
variables predicting the development of PoAF.</p><p>According to the US Endocrine Society guidelines, vitamin D deficiency was defined as
25(OH) vitamin D level less than 20 ng/mL, vitamin D insufficiency was defined as
25(OH) vitamin D level between 21 and 29 ng/mL<sup>[</sup><sup><xref rid="r24" ref-type="bibr">24</xref></sup><sup>]</sup>. The Institute of Medicine found that
25(OH) vitamin D serum levels of 16 ng/mL covers the requirements of approximately
50% of the population<sup>[</sup><sup><xref rid="r25" ref-type="bibr">25</xref></sup><sup>]</sup>. There are different opinions regarding the cut-off
values for insufficient or deficient vitamin D level. In our study, 25(OH) vitamin D
levels were as 12.13&#x000b1;7.98 ng/mL (range: 2.8-36.8), (percentiles 25; 6.67
ng/mL, percentiles 75; 15.35 ng/mL) in patients without PoAF. In patients with PoAF,
25(OH) vitamin D levels were found as 7.49&#x000b1;3.81 ng/mL (range: 1.5-20.5),
(percentiles 25; 4.7 ng/mL, percentiles 75; 9.05 ng/mL). When these levels are taken
into consideration, a vast majority of the patients in our study are in the vitamin
D deficiency group according to the guidelines. It may be due to study period in the
winter months. The average blood vitamin D level of the population studied is not
clear. Although the blood vitamin D levels in most patients were insufficient
according to the guidelines, the cut-off value that 7.65 ng/dl for vitamin D in this
study was found to be statistically significant. Furthermore, it was determined a
cut-off level of 7.65 for 25(OH) vitamin D level for predicting PoAF with a
sensitivity of 60% and a specificity of 64% (AUC: 0.679,
<italic>P</italic>=0.002).</p><p>In our study, the risk factors for arrhythmia were minimized and provided homogeneity
between the groups; lower vitamin D levels would not affect the outcome of the
study. It was more important for us that statistical differences in terms of vitamin
D levels between groups are statistically significant predictors of postoperative AF
development. On the other hand, our study had homogeneity. For this reason, the risk
factors for development atrial fibrillation as COPD and valvular heart diseases were
excluded. Therefore, the results of our study may be more specific in terms of the
relationship between lower vitamin D levels and PoAF.</p><sec><title>Limitations of the Study</title><p>Our study has some limitations. The small sample size may be considered as the
first limitation of this study, but the excess of exclusion criteria minimized
the risk factors for PoAF. This may allow us to ignore the size of the sample,
which appears to be a limitation of study. Secondly, parathyroid hormone levels
were not measured. Also our work was only carried out in the winter and spring
seasons. Further prospective studies with a larger number of patients are
required.</p></sec></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>Many factors contribute to the development of AF after CABG. Many studies have been
done on PoAF development. The lack of vitamin D can cause some of cardiovascular
disease. In this study, lower vitamin D level was found to be an independent
predictor of the development of PoAF. Low vitamin D level may be one of the reasons
for PoAF development.</p><table-wrap id="t5" orientation="portrait" position="float"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="95%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">KK&#x000d6;</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; agreement to be accountable for
all aspects of the work in ensuring that questions related to the
accuracy or integrity of any part of the work are appropriately
investigated and resolved; final approval of the version to be
published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">USS</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; final approval of the version
to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FT</td><td align="left" valign="top" rowspan="1" colspan="1">Drafting the work or revising it
critically for important intellectual content; final approval of the
version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NK</td><td align="left" valign="top" rowspan="1" colspan="1">Drafting the work or revising it
critically for important intellectual content; final approval of the
version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x0015e;Y</td><td align="left" valign="top" rowspan="1" colspan="1">Drafting the work or revising it
critically for important intellectual content; agreement to be
accountable for all aspects of the work in ensuring that questions
related to the accuracy or integrity of any part of the work are
appropriately investigated and resolved; final approval of the
version to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at Department of Cardiovascular Surgery, Bursa Yuksek
Ihtisas Training and Research Hospital, University of Health Sciences,
Y&#x00131;ld&#x00131;r&#x00131;m/Bursa, Turkey.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><fn-group><fn fn-type="supported-by"><p>Financial support: We received financial support from Training and Project
Committee of Bursa Y&#x000fc;ksek &#x00130;htisas Training and Research Hospital.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><ack><title>ACKNOWLEDGMENTS</title><p>We thank the Associated Professor Dr. Kagan Huysal, for invaluable support in
measuring vitamin D levels.</p></ack><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thor&#x000e9;n</surname><given-names>E</given-names></name><name><surname>Hellgren</surname><given-names>L</given-names></name><name><surname>St&#x000e5;hle</surname><given-names>E</given-names></name></person-group><article-title>High incidence of atrial fibrillation after coronary
surgery</article-title><source>Interact Cardiovasc Thorac Surg</source><year>2016</year><volume>22</volume><issue>2</issue><fpage>176</fpage><lpage>180</lpage><pub-id pub-id-type="pmid">26598007</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lugg</surname><given-names>ST</given-names></name><name><surname>Howells</surname><given-names>PA</given-names></name><name><surname>Thickett</surname><given-names>DR</given-names></name></person-group><article-title>Optimal vitamin D supplementation levels for cardiovascular
disease protection</article-title><source>Dis Markers</source><year>2015</year><volume>2015</volume><elocation-id>864370</elocation-id><pub-id pub-id-type="pmid">26435569</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mozos</surname><given-names>I</given-names></name><name><surname>Marginean</surname><given-names>O</given-names></name></person-group><article-title>Links between vitamin D deficiency and cardiovascular
diseases</article-title><source>Biomed Res Int</source><year>2015</year><volume>2015</volume><elocation-id>109275</elocation-id><pub-id pub-id-type="pmid">26000280</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rez-Hern&#x000e1;ndez</surname><given-names>N</given-names></name><name><surname>Aptilon-Duque</surname><given-names>G</given-names></name><name><surname>Nostroza-Hern&#x000e1;ndez</surname><given-names>MC</given-names></name><name><surname>Vargas-Alarc&#x000f3;n</surname><given-names>G</given-names></name><name><surname>Rodr&#x000ed;guez-P&#x000e9;rez</surname><given-names>JM</given-names></name><name><surname>Blachman-Braun</surname><given-names>R</given-names></name></person-group><article-title>Vitamin D and its effects on cardiovascular diseases: a
comprehensive review</article-title><source>Korean J Intern Med</source><year>2016</year><volume>31</volume><issue>6</issue><fpage>1018</fpage><lpage>1029</lpage><pub-id pub-id-type="pmid">27117316</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vitezova</surname><given-names>A</given-names></name><name><surname>Cartolano</surname><given-names>NS</given-names></name><name><surname>Heeringa</surname><given-names>J</given-names></name><name><surname>Zillikens</surname><given-names>MC</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Franco</surname><given-names>OH</given-names></name><etal/></person-group><article-title>Vitamin D and the risk of atrial fibrillation: the Rotterdam
Study</article-title><source>PLoS One</source><year>2015</year><volume>10</volume><issue>5</issue><elocation-id>e0125161</elocation-id><pub-id pub-id-type="pmid">25933375</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holick</surname><given-names>MF</given-names></name></person-group><article-title>Vitamin D status: measurement, interpretation, and clinical
application</article-title><source>Ann Epidemiol</source><year>2009</year><volume>19</volume><issue>2</issue><fpage>73</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">18329892</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maisel</surname><given-names>WH</given-names></name><name><surname>Rawn</surname><given-names>JD</given-names></name><name><surname>Stevenson</surname><given-names>WG</given-names></name></person-group><article-title>Atrial fibrillation after cardiac surgery</article-title><source>Ann Intern Med</source><year>2001</year><volume>135</volume><issue>12</issue><fpage>1061</fpage><lpage>1073</lpage><pub-id pub-id-type="pmid">11747385</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mariscalco</surname><given-names>G</given-names></name><name><surname>Engstr&#x000f6;m</surname><given-names>KG</given-names></name></person-group><article-title>Postoperative atrial fibrillation is associated with late
mortality after coronary surgery, but not after valvular
surgery</article-title><source>Ann Thorac Surg</source><year>2009</year><volume>88</volume><issue>6</issue><fpage>1871</fpage><lpage>1876</lpage><pub-id pub-id-type="pmid">19932252</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banach</surname><given-names>M</given-names></name><name><surname>Rysz</surname><given-names>J</given-names></name><name><surname>Drozdz</surname><given-names>JA</given-names></name><name><surname>Okonski</surname><given-names>P</given-names></name><name><surname>Misztal</surname><given-names>M</given-names></name><name><surname>Barylski</surname><given-names>M</given-names></name><etal/></person-group><article-title>Risk factors of atrial fibrillation following coronary artery
bypass grafting: a preliminary report</article-title><source>Circ J</source><year>2006</year><volume>70</volume><issue>4</issue><fpage>438</fpage><lpage>441</lpage><pub-id pub-id-type="pmid">16565561</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathew</surname><given-names>JP</given-names></name><name><surname>Fontes</surname><given-names>ML</given-names></name><name><surname>Tudor</surname><given-names>IC</given-names></name><name><surname>Ramsay</surname><given-names>J</given-names></name><name><surname>Duke</surname><given-names>P</given-names></name><name><surname>Mazer</surname><given-names>CD</given-names></name><etal/><collab>Investigators of the Ischemia Research and Education
Foundation</collab><collab>Multicenter Study of Perioperative Ischemia Research Group</collab></person-group><article-title>A multicenter risk index for atrial fibrillation after cardiac
surgery</article-title><source>JAMA</source><year>2004</year><volume>291</volume><issue>14</issue><fpage>1720</fpage><lpage>1729</lpage><pub-id pub-id-type="pmid">15082699</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faustino</surname><given-names>A</given-names></name><name><surname>Provid&#x000ea;ncia</surname><given-names>R</given-names></name><name><surname>Barra</surname><given-names>S</given-names></name><name><surname>Paiva</surname><given-names>L</given-names></name><name><surname>Trigo</surname><given-names>J</given-names></name><name><surname>Botelho</surname><given-names>A</given-names></name><etal/></person-group><article-title>Which method of left atrium size quantification is the most
accurate to recognize thromboembolic risk in patients with non-valvular
atrial fibrillation?</article-title><source>Cardiovasc Ultrasound</source><year>2014</year><volume>12</volume><fpage>28</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">25052699</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nisanoglu</surname><given-names>V</given-names></name><name><surname>Erdil</surname><given-names>N</given-names></name><name><surname>Aldemir</surname><given-names>M</given-names></name><name><surname>Ozgur</surname><given-names>B</given-names></name><name><surname>Berat Cihan</surname><given-names>H</given-names></name><name><surname>Yologlu</surname><given-names>S</given-names></name><etal/></person-group><article-title>Atrial fibrillation after coronary artery bypass grafting in
elderly patients: incidence and risk factor analysis</article-title><source>Thorac Cardiovasc Surg</source><year>2007</year><volume>55</volume><issue>1</issue><fpage>32</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">17285471</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Jong</surname><given-names>MJ</given-names></name><name><surname>Morton</surname><given-names>PG</given-names></name></person-group><article-title>Predictors of atrial dysrhythmias for patients undergoing
coronary artery bypass grafting</article-title><source>Am J Crit Care</source><year>2000</year><volume>9</volume><issue>6</issue><fpage>388</fpage><lpage>396</lpage><pub-id pub-id-type="pmid">11072554</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerit</surname><given-names>L</given-names></name><name><surname>Kemal</surname><given-names>H</given-names></name><name><surname>Gulsen</surname><given-names>K</given-names></name><name><surname>Ozcem</surname><given-names>B</given-names></name><name><surname>Cerit</surname><given-names>Z</given-names></name><name><surname>Duygu</surname><given-names>H</given-names></name></person-group><article-title>Relationship between Vitamin D and the development of atrial
fibrillation after on-pump coronary artery bypass graft
surgery</article-title><source>Cardiovasc J Afr</source><year>2017</year><volume>28</volume><issue>2</issue><fpage>104</fpage><lpage>107</lpage><pub-id pub-id-type="pmid">27701486</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ge&#x000e7;men</surname><given-names>&#x000c7;</given-names></name><name><surname>Bab&#x000fc;r G&#x000fc;ler</surname><given-names>G</given-names></name><name><surname>Erdo&#x0011f;an</surname><given-names>E</given-names></name><name><surname>Hatipo&#x0011f;lu</surname><given-names>S</given-names></name><name><surname>G&#x000fc;ler</surname><given-names>E</given-names></name><name><surname>Y&#x00131;lmaz</surname><given-names>F</given-names></name><etal/></person-group><article-title>SYNTAX score predicts postoperative atrial fibrillation in
patients undergoing on-pump isolated coronary artery bypass grafting
surgery</article-title><source>Anatol J Cardiol</source><year>2016</year><volume>16</volume><issue>9</issue><fpage>655</fpage><lpage>661</lpage><pub-id pub-id-type="pmid">27488747</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gode</surname><given-names>S</given-names></name><name><surname>Aksu</surname><given-names>T</given-names></name><name><surname>Demirel</surname><given-names>A</given-names></name><name><surname>Sunbul</surname><given-names>M</given-names></name><name><surname>Gul</surname><given-names>M</given-names></name><name><surname>Bak&#x00131;r</surname><given-names>I</given-names></name><etal/></person-group><article-title>Effect of vitamin D deficiency on the development of
postoperative atrial fibrillation in coronary artery bypass
patients</article-title><source>J Cardiovasc Thorac Res</source><year>2016</year><volume>8</volume><issue>4</issue><fpage>140</fpage><lpage>146</lpage><pub-id pub-id-type="pmid">28210468</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shadvar</surname><given-names>K</given-names></name><name><surname>Ramezani</surname><given-names>F</given-names></name><name><surname>Sanaie</surname><given-names>S</given-names></name><name><surname>Maleki</surname><given-names>TE</given-names></name><name><surname>Arbat</surname><given-names>BK</given-names></name><name><surname>Nagipour</surname><given-names>B</given-names></name></person-group><article-title>Relationship between plasma level of vitamin D and post operative
atrial fibrillation in patients undergoing CABG</article-title><source>Pak J Med Sci</source><year>2016</year><volume>32</volume><issue>4</issue><fpage>900</fpage><lpage>904</lpage><pub-id pub-id-type="pmid">27648036</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demir</surname><given-names>M</given-names></name><name><surname>Uyan</surname><given-names>U</given-names></name><name><surname>Melek</surname><given-names>M</given-names></name></person-group><article-title>The effects of vitamin D deficiency on atrial
fibrillation</article-title><source>Clin Appl Thromb Hemost</source><year>2014</year><volume>20</volume><issue>1</issue><fpage>98</fpage><lpage>103</lpage><pub-id pub-id-type="pmid">22826443</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eleftheriadis</surname><given-names>T</given-names></name><name><surname>Antoniadi</surname><given-names>G</given-names></name><name><surname>Liakopoulos</surname><given-names>V</given-names></name><name><surname>Stefanidis</surname><given-names>I</given-names></name><name><surname>Galaktidou</surname><given-names>G</given-names></name></person-group><article-title>Inverse association of serum 25-hydroxyvitamin D with markers of
inflammation and suppression of osteoclastic activity in hemodialysis
patients</article-title><source>Iran J Kidney Dis</source><year>2012</year><volume>6</volume><issue>2</issue><fpage>129</fpage><lpage>135</lpage><pub-id pub-id-type="pmid">22388612</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korantzopoulos</surname><given-names>P</given-names></name><name><surname>Kolettis</surname><given-names>TM</given-names></name><name><surname>Galaris</surname><given-names>D</given-names></name><name><surname>Goudevenos</surname><given-names>JA</given-names></name></person-group><article-title>The role of oxidative stress in the pathogenesis and perpetuation
of atrial fibrillation</article-title><source>Int J Cardiol</source><year>2007</year><volume>115</volume><issue>2</issue><fpage>135</fpage><lpage>143</lpage><pub-id pub-id-type="pmid">16764958</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Ng</surname><given-names>CY</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><etal/></person-group><article-title>Meta-analysis of vitamin D deficiency and risk of atrial
fibrillation</article-title><source>Clin Cardiol</source><year>2016</year><volume>39</volume><issue>9</issue><fpage>537</fpage><lpage>543</lpage><pub-id pub-id-type="pmid">27556176</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rienstra</surname><given-names>M</given-names></name><name><surname>Cheng</surname><given-names>S</given-names></name><name><surname>Larson</surname><given-names>MG</given-names></name><name><surname>McCabe</surname><given-names>EL</given-names></name><name><surname>Booth</surname><given-names>SL</given-names></name><name><surname>Jacques</surname><given-names>PF</given-names></name><etal/></person-group><article-title>Vitamin D status is not related to development of atrial
fibrillation in the community</article-title><source>Am Heart J</source><year>2011</year><volume>162</volume><issue>3</issue><fpage>538</fpage><lpage>541</lpage><pub-id pub-id-type="pmid">21884873</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skuladottir</surname><given-names>GV</given-names></name><name><surname>Cohen</surname><given-names>A</given-names></name><name><surname>Arnar</surname><given-names>DO</given-names></name><name><surname>Hougaard</surname><given-names>DM</given-names></name><name><surname>Torfason</surname><given-names>B</given-names></name><name><surname>Palsson</surname><given-names>R</given-names></name><etal/></person-group><article-title>Plasma 25-hydroxyvitamin D2 and D3 levels and incidence of
postoperative atrial fibrillation</article-title><source>J Nutr Sci</source><year>2016</year><volume>5</volume><elocation-id>e10</elocation-id><pub-id pub-id-type="pmid">27066255</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holick</surname><given-names>MF</given-names></name><name><surname>Binkley</surname><given-names>NC</given-names></name><name><surname>Bischoff-Ferrari</surname><given-names>HA</given-names></name><name><surname>Gordon</surname><given-names>CM</given-names></name><name><surname>Hanley</surname><given-names>DA</given-names></name><name><surname>Heaney</surname><given-names>RP</given-names></name><etal/></person-group><article-title>Evaluation, treatment, and prevention of vitamin D deficiency: an
Endocrine Society clinical practice guideline</article-title><source>J Clin Endocrinol Metab</source><year>2011</year><volume>96</volume><issue>7</issue><fpage>1911</fpage><lpage>1930</lpage><pub-id pub-id-type="pmid">21646368</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Institute of Medicine</collab></person-group><source>Dietary reference intakes for calcium and vitamin D</source><publisher-loc>Washington</publisher-loc><publisher-name>The National Academies Press</publisher-name><year>2011</year></element-citation></ref></ref-list></back></article>